Assessing the impact of contraceptive use on reproductive cancer risk among women of reproductive age—a systematic review
2024

Impact of Contraceptive Use on Cancer Risk in Women

Sample size: 51 publication Evidence: moderate

Author Information

Author(s): Jahanfar Shayesteh, Mortazavi Julie, Lapidow Amy, Cu Cassandra, Al Abosy Jude, Morris Kathyrn, Becerra-Mateus Juan Camilo, Steinfeldt Meredith, Maurer Olivia, Bohang Jiang, Andrenacci Paola, Badawy Marwa, Ali Moazzam

Primary Institution: Tufts University School of Medicine

Hypothesis

What is the association between modern contraceptive use and the risk of breast and reproductive cancers among women of reproductive age?

Conclusion

Modern contraceptives are associated with a reduced risk of ovarian and endometrial cancers, but an increased risk of cervical cancer, especially among users.

Supporting Evidence

  • Hormonal contraceptive users had a 36% lower risk of ovarian cancer.
  • Contraceptive users had a significantly lower risk of endometrial cancer incidence.
  • The rate ratio of cervical cancer was higher among non-users compared to hormonal contraceptive users.
  • No significant association was found between contraceptive use and breast cancer risk among healthy women.
  • BRCA1/2 mutation carriers using oral contraceptives showed a heightened risk of breast cancer.

Takeaway

Using birth control can help protect women from certain types of cancer, but it might increase the risk of cervical cancer.

Methodology

A systematic review was conducted following PRISMA guidelines, including randomized controlled trials, cohort studies, and case-control studies comparing cancer outcomes between contraceptive users and non-users.

Potential Biases

Recall bias and information bias were concerns due to reliance on self-reported contraceptive use.

Limitations

The study did not account for the age at first use of contraceptives, time since last use, or demographic characteristics, and there was limited information on specific hormonal contraceptive regimens.

Participant Demographics

Women of reproductive age (14–49 years).

Statistical Information

Confidence Interval

95% CI 0.60–0.68

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fgwh.2024.1487820

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication